期刊文献+

分化型甲状腺癌肺转移临床诊断研究进展 被引量:7

Research Progress on Clinical Diagnosis for Lung Metastases from Differentiated Thyroid Carcinoma
原文传递
导出
摘要 分化型甲状腺癌(DTC)肺转移是DTC较常见的转移性疾病,因其起病隐匿且发展缓慢,临床诊断较为困难。本文就可能检测出DTC肺转移的诊断手段如血清学检查、核素显像及其他影像学检查等在DTC肺转移早期诊断、复发及疗效评价等方面的研究现状与进展进行了简要综述,以期促进分化型甲状腺癌肺转移诊断水平的进一步提高。 Lung metastases are more common in metastatic disease in differentiated thyroid carcinoma (DTC). Because of its insidious onset and slow development, clinical diagnosis is relatively difficult. Some possible diagnostic methods for detecting the lung metastasis of DTC including serological examination, radionuclide imaging and other medical imaging patterns are discussed in this paper. The progress and the current situation about investigation of those modalities which are in the early diagnosis, recurrent and clinical evaluation for the lung metastasis of DTC are briefly reviewed. Therefore, it is expected to promote DTC with lung metastasis to a higher diagnostic level.
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2014年第4期950-954,共5页 Journal of Biomedical Engineering
基金 四川省教育厅课题资助项目(08zb094)
关键词 分化型甲状腺癌 肺转移 放射性碘 诊断 differentiated thyroid cancer (DTC) lung metastases radioiodine diagnosis
  • 相关文献

参考文献27

  • 1杨爱民,薛建军,高蕊,邓惠兴,喻铭启.^(131)碘全身显像、甲状腺球蛋白测定及颈部超声检查在分化型甲状腺癌^(131)碘治疗随访中的意义[J].现代肿瘤医学,2010,18(3):471-473. 被引量:9
  • 2COOPER D S, DOHERTY G M, HAUGEN B R, et al. Re- vised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11) : 1167-1214.
  • 3李少华,王自正,邵国强,王峰,张乐乐,蒋娥,孟庆乐.抗甲状腺球蛋白抗体和^(18)F-FDG符合线路显像在分化型甲状腺癌随访中的临床应用[J].中国医学影像技术,2008,24(9):1465-1468. 被引量:7
  • 4GREWAL R K, TUTTLE R M, FOX J, et al. The effect of posttherapy laxi SPECT/CT on risk classification and man- agement of patients with differentiated thyroid cancer [J]. J Nucl Med, 2010, 51(9): 1361-1367.
  • 5OH J R, BYUN B H, HONG S P, et al. Comparison of ^131 I whole-body imaging, 131I SPECT/CT, and 18F-FDG PET/ CT in the detection of metastatic thyroid cancer[J]. Eur J Nucl Med Mol Imaging, 2011, 38(8): 1459-1468.
  • 6PAPATHANASSIOU D, BRUNA-MURAILLE C, LIEHN J C, et al. Positron emission tomography in oncology: present and future of PET and PET/CT [J]. Critical Reviews in On- cology/Hematology, 2009, 72(3): 239-254.
  • 7MA C, XIE J, LOU Y, et al. The role of TSH for 18F-FDG- PET in the diagnosis of recurrence and metastases of differen- tiated thyroid carcinoma with elevated thyroglobulin and nega- tive scan: a meta-analysis [J]. European Journal of Endocri- nology/ European Federation of Endocrine Societies, 2010, 163(2) : 177-183.
  • 8KIM M H, H O J, KO S H, et al. Role of [(18F)]-flourodeoxy-D-glucose Positron Emission Tomography and Computer Tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients follow- ing initial radioactive Iodine ablation therapy [J]. Thyroid, 2012, 22(2): 157-164.
  • 9SEO Y L, YOON D Y, BAEK S, et al. Detection of neck re- currence in patients with differentiated thyroid cancer: com- parison of ultrasound, contrast-enhanced CT and (18)F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET/CT in recurrent thyroid cancer)[J]. Eur Radiol, 2012, 22(10): 2246-2254.
  • 10AHN B C, LEE S W, LEE J, et al. Pulmonary aspergilloma mimicking metastasis from papillary thyroid cancer J]. Thy- roid, 2011, 21(5): 555-558.

二级参考文献78

  • 1潘明志,田蓉.Tg阳性与诊断剂量^(131)I-WBS阴性甲癌患者的处理策略研究[J].华西医学,2005,20(2):337-337. 被引量:7
  • 2赖远辉,李晓曦,王深明,李松奇.甲状腺结节钙化的临床价值[J].中国实用外科杂志,2005,25(12):732-733. 被引量:16
  • 3川玲,赵文锐,朱家瑞,许根祥,王新强,高春华,方庭正.分化型甲状腺癌^(131)I治疗后SPECT/CT融合显像的临床研究[J].中国医学影像技术,2006,22(9):1412-1414. 被引量:14
  • 4胡莹莹,蒋宁一.^(131)Ⅰ治疗分化型甲状腺癌的现状和进展[J].国际放射医学核医学杂志,2006,30(6):343-346. 被引量:11
  • 5Baudin E, Do Cao C, Cailleux AF, et al. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab, 2003,88(3) : 1107-1011.
  • 6Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol, 2007,31(8) : 1256-1264.
  • 7Syed R, Bomanji JB, Nagabhushan N, et al. Impact of combined ^18F FDG PET/CT in head and neck tumors. Br J Cancer, 2005,92 (6) : 1046-1050.
  • 8Stokkel MP, Duchateau CS, Dragoiescu C. The value of FDGPET in the follow up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging, 2006,50(1) :78-87.
  • 9Nahas Z, Goldenberg D, Fakhry C, et al. The role of positron emission tomography/computed tomography in the management of recurrent papillary thyroid carcinoma. Laryngoscope, 2005, 115 (2) :237-243.
  • 10Yamaga LY, Cunha MI., Wagner J, et al. Diagnostic value of positron emission tomography/computed tomography with fluorine-18 fluordeoxyglueose in patients with differentiated thyroid gland carcinoma, high thyroglobulin serum levels and negative iodine whole body scan. Arq Bras Endocrinol Metabol, 2007,51(4) : 581- 586.

共引文献55

同被引文献86

  • 1李茵,李秋梨,郭朱明.甲状腺髓样癌靶向治疗[J].中国实用外科杂志,2020(9):1052-1055. 被引量:6
  • 2无,王宇,田文,嵇庆海,葛明华,张浩.甲状腺髓样癌诊断与治疗中国专家共识(2020版)[J].中国实用外科杂志,2020(9):1012-1020. 被引量:69
  • 3杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1520
  • 4钱波,蔡寒青,冯洁.干细胞、肿瘤干细胞与肿瘤发生[J].世界华人消化杂志,2007,15(13):1526-1531. 被引量:7
  • 5Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 6Rubello D,Rampin L,Nanni C,et al.The role of 18-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma:a prospective study[J].European Journal of Surgical Oncology,2008,34(5):581-586.
  • 7Sebastian S O,Gonzalez J M,Paricio P P,et al.Papillary thyroid carcinoma:prognostic index for survival including the histological variety[J].Arch Surg,2000,135(3):272-277.
  • 8Uhry Z, Colonna M, Remontet L, et al. Estimating infra-national and national thyroid cancer incidence in France from cancer regis- tries data and national hospital discharge database [ J ]. Eur J Epi- demiol, 2007,22 ( 9 ) : 607 -614.
  • 9Liu WK, Xu SX, Che CT. Anti-proliferative effect of ginseng sapo- nins on human prostate cancer cell line [ J ]. Life Sci, 2000,67 ( 11 ) : 1297-1306.
  • 10Park IH, Piao LZ, Kwon SW, et al. Cytotoxic dammarane glyco- sides from processed ginseng [ J ]. Chem Pharm Bull ( Tokyo ), 2002,50(4) :538-540.

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部